Alternatively, the generated anti-CD33 Nbs could easily be employed to construct a Bi-specific T-cell engagers (BiTE)-like format, so that CD33 expressing AML blasts become engaged with T cells. The gene discussed is CD33; the disease is acute myeloid leukemia.